| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 06/04/2002 | US6399112 Chinese herbs extract |
| 06/04/2002 | US6399083 Cosmetic skin care with extracts from chick peas and retinol and retinyl esters |
| 06/04/2002 | CA2257016C Imidazolidin-4-one derivatives useful as anticancer agents |
| 06/04/2002 | CA2227967C Topical compositions having improved skin feel |
| 06/01/2002 | CA2364094A1 Astringent composition and method of use |
| 05/30/2002 | WO2002042335A1 Polysaccharide compound having immune stimulating activity |
| 05/30/2002 | WO2002042332A2 Truncated cd200 |
| 05/30/2002 | WO2002042331A1 Basic fibroblastic growth factor with a specific collagen binding domain |
| 05/30/2002 | WO2002042306A1 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 05/30/2002 | WO2002042298A1 Aminothiazoles and their use as adenosine receptor antagonists |
| 05/30/2002 | WO2002042296A1 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 05/30/2002 | WO2002042292A2 Indol derivative and their use as inhibitors of p38 kinase |
| 05/30/2002 | WO2002042280A2 Pyrimidine derivatives |
| 05/30/2002 | WO2002042278A2 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 05/30/2002 | WO2002042273A2 Acid derivatives useful as serine protease inhibitors |
| 05/30/2002 | WO2002042269A1 3-arylindole derivatives and their use as cb2 receptor agonists |
| 05/30/2002 | WO2002042248A2 Naphthalene derivatives |
| 05/30/2002 | WO2002042247A1 Retiferol derivatives and their use in the treatment of skin diseases or conditions associated with photodamage |
| 05/30/2002 | WO2002041909A1 Method and preparations having effect against allergic symptoms |
| 05/30/2002 | WO2002041908A1 Process for preparing aqueous extracts of plants and extracts so obtained |
| 05/30/2002 | WO2002041885A2 Treatment of inflammation and associated complications using pseudohalides |
| 05/30/2002 | WO2002041865A1 Cosmetic method of treating skin |
| 05/30/2002 | WO2002041859A1 Use of cyclosporin a 7-thioamide derivatives for hair growth |
| 05/30/2002 | WO2002041858A1 Use of cyclosporin 7-thioamide derivatives for hair growth |
| 05/30/2002 | WO2002041853A1 O/w emulsion composition and method of preparing the same |
| 05/30/2002 | WO2002041843A2 Antiinflammation agents |
| 05/30/2002 | WO2002041835A2 Estrogen receptor modulators |
| 05/30/2002 | WO2002041832A2 Compositions having comfrey and methods for reducing retinoid-induced skin irritation |
| 05/30/2002 | WO2002022599A3 Chemokine receptor binding heterocyclic compounds |
| 05/30/2002 | WO2002020736A9 Proteases |
| 05/30/2002 | WO2002018441A3 Electroprocessed fibrin-based matrices and tissues |
| 05/30/2002 | WO2002002068A3 Cosmetic skin care compositions and containing gum mastic |
| 05/30/2002 | WO2002000611A3 Fmoc-l-leucine and derivatives thereof as ppar-gamma agonists |
| 05/30/2002 | WO2001098270A3 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 05/30/2002 | WO2001095928A3 Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking lfa-1 mediated adhesion |
| 05/30/2002 | WO2001095894A3 Topical water-based anti-inflammatory compositions |
| 05/30/2002 | WO2001092333A3 Use of adnf for enhancing learning and memory |
| 05/30/2002 | WO2001087979A3 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci |
| 05/30/2002 | WO2001087330A3 Compositions and methods for achieving immune suppression |
| 05/30/2002 | WO2001085686A3 Multicyclic compounds and the use as inhibitors of parp, vegfr2 and mlk3 enzymes |
| 05/30/2002 | WO2001074780A8 Chemical complex comprising a pyridine carboxy derivative and an h2 histamine receptor antagonist |
| 05/30/2002 | WO2001050994A8 Topical medicated bioadhesive compositions and methods of use and preparation thereof |
| 05/30/2002 | WO2001042273A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 05/30/2002 | WO2000078952A8 Human rna metabolism proteins (rmep) |
| 05/30/2002 | US20020065416 Anti-inflammatory agents |
| 05/30/2002 | US20020065336 Sterilized cyanoacrylate solutions containing thickeners |
| 05/30/2002 | US20020065315 For therapy and prophylaxis of asthma, cystic fibrosis, chronic obstructive pulmonary disease and rhinorrhea, convulsions, vascular spasms, coronary artery spasms, renal disorders, polycystic kidney disease, bladder spasms, etc. |
| 05/30/2002 | US20020065302 Cyclic AMP-specific phosphodiesterase inhibitors |
| 05/30/2002 | US20020065300 Administering to a mammal a pigmentation-changing effective amount of a Bowman-Birk Inhibitor or of natural extract containing a Bowman-Birk Inhibitor |
| 05/30/2002 | US20020065296 Administering heteroarylurea compound for therapy of cytokine mediated diseases and proteolytic enzyme mediated diseases |
| 05/30/2002 | US20020065285 Aromatic heterocyclic compounds as antiinflammatory agents |
| 05/30/2002 | US20020065284 Dipeptide derivatives |
| 05/30/2002 | US20020065269 3-Sulfonylamino-c5 to c8-methyleneimino-2-carboxylic acid compound is effective for prophylaxis and treatment of inflammation, tissue degradation, cancer, fibrosis and related diseases |
| 05/30/2002 | US20020065231 Method for producing biologically active products |
| 05/30/2002 | US20020065222 Method of stimulation hair growth |
| 05/30/2002 | US20020065220 For use in diagnosis and therapy of disorders treating disorders related to these novel human immunoglobulin-like (Ig- like) proteins |
| 05/30/2002 | US20020064856 Novel proteases |
| 05/30/2002 | US20020064826 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 05/30/2002 | US20020064823 Nucleotide sequences which code binding protein for use in human therapeutics and gene therapy |
| 05/30/2002 | US20020064565 Treating an eye infections; cleansing a contact lens in place on an eye |
| 05/30/2002 | US20020064540 Composition, particularly cosmetic, combining DHEA and/or a precursor or derivative thereof, and at least an agent for increasing glycosaminoglycan synthesis |
| 05/30/2002 | US20020064539 Cosmetic or dermatological composition contacting at least one natural or recombinant spider silk or an analog |
| 05/30/2002 | US20020064527 Administering agents that hinder CD30/CD30L (CD30L=ligand of CD30) binding; animal model of arthritis for drug screening |
| 05/30/2002 | US20020064524 Formulation for topical non-invasive application in vivo |
| 05/30/2002 | US20020064516 Pharmaceutical compositions comprising TGF-beta |
| 05/30/2002 | US20020064507 Compositions comprising at least one UV screening agent and at least one flavylium salt which is unsubstituted in position 3, for coloring the skin, and uses thereof |
| 05/30/2002 | US20020062835 Methods of modulating hair growth |
| 05/30/2002 | CA2430113A1 Process for preparing aqueous extracts of plants and extracts so obtained |
| 05/30/2002 | CA2429976A1 Polysaccharide compound having immune stimulating activity |
| 05/30/2002 | CA2429630A1 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 05/30/2002 | CA2429605A1 Indol derivative and their use as inhibitors of p38 kinase |
| 05/30/2002 | CA2429579A1 Truncated cd200 |
| 05/30/2002 | CA2429570A1 Pyrimidine derivatives |
| 05/30/2002 | CA2429442A1 Aminothiazoles and their use as adenosine receptor antagonists |
| 05/30/2002 | CA2428902A1 Compositions having comfrey and methods for reducing retinoid-induced skin irritation |
| 05/30/2002 | CA2428634A1 Cosmetic method of treating skin |
| 05/30/2002 | CA2428470A1 Retiferol derivatives and their use in the treatment of skin diseases or conditions associated with photodamage |
| 05/30/2002 | CA2428191A1 Acid derivatives useful as serine protease inhibitors |
| 05/30/2002 | CA2427444A1 3-arylindole derivatives and their use as cb2 receptor agonists |
| 05/30/2002 | CA2427284A1 Antiinflammation agents |
| 05/30/2002 | CA2363951A1 Modulating ramp activity |
| 05/29/2002 | EP1208849A1 Use of bromelain for the treatment of inflammatory diseases and for adjuvant therapy during wound healing process |
| 05/29/2002 | EP1208847A2 Pharmaceutical compositions for treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin A and 40-O(2-hydroxyethyl)-rapamycin |
| 05/29/2002 | EP1208842A2 Regulation of the immune system |
| 05/29/2002 | EP1208377A1 Melanocortin metallopeptide constructs, combinatorial libraries and applications |
| 05/29/2002 | EP1208201A2 Compositions and methods for the treatment of immune related diseases |
| 05/29/2002 | EP1208198A2 Egfh2 genes and gene products |
| 05/29/2002 | EP1208196A1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
| 05/29/2002 | EP1208104A2 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 05/29/2002 | EP1208103A2 Reverse-turn mimetics and methods relating thereto |
| 05/29/2002 | EP1208101A1 Vitronectin receptor antagonists useful for the treatment of strokes |
| 05/29/2002 | EP1208100A1 Selective antagonists of a2b adenosine receptors |
| 05/29/2002 | EP1208099A1 4,5-diaryloxazole compounds with prostaglandin i2 (pgi2) agonistic activity |
| 05/29/2002 | EP1208096A1 Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity |
| 05/29/2002 | EP1207882A1 Acyclic and cyclic amine derivatives |
| 05/29/2002 | EP1207881A1 Pharmaceutical agent comprising a benzamide derivative as active ingredient |
| 05/29/2002 | EP1207879A1 Nicotine receptor agonists in stem cell and progenitor cell recruitment |
| 05/29/2002 | EP1207863A2 New uses for potassium channel openers, such as the treatment of epilepsy |
| 05/29/2002 | EP1207840A1 Pharmaceutical compositions and methods for reducing the appearance of cellulite |
| 05/29/2002 | EP0799023B1 Use of flavonoids as immunomodulating or immuno-protective agents in cosmetic and dermatological preparations |